CXCR3 and CCR5 ligands in rheumatoid arthritis synovium

被引:277
作者
Patel, DD [1 ]
Zachariah, JP
Whichard, LP
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Rheumatol Allergy & Clin Immunol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Arthrit Ctr, Durham, NC 27710 USA
关键词
chemokine; rheumatoid arthritis; CCR5; CXCR3; IP-10; Mig; Mip-1; beta;
D O I
10.1006/clim.2000.4957
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathogenesis of rheumatoid arthritis (RA) may be mediated by Th1-type T cells. Since chemokine receptors CXCR3 and CCR5 are preferentially expressed on Th1 cells, we tested the expression and regulation of several chemokines, including those that signal through CXCR3 (interferon-gamma -inducible protein of 10 kDa, IP-10, CXCL10; and monokine induced by interferon-gammay, Mig, CXCL9) and CCR5 (macrophage inflammatory protein (Mip)-1 alpha, CCL3; and Mip-1 beta, CCL4) in RA synovial fluids, synovial tissues, and blood. Synovial fluid (SF) protein levels of IP-10 (32.1 +/- 10.5 ng/ml), Mig (15.0 +/- 6.4 ng/ml), Mip-1 beta (0.7 +/- 0.3 ng/ml), and Mip-1 alpha (0.8 +/- 0.1 ng/ml) were 100-, 50-, 25-, and 2-fold elevated in RASF compared to control SF (P < 0.001, P < 0.001, P < 0.001, and P < 0.02, respectively). Tissue levels of IP-10, Mig, and Mip-1 beta were significantly higher in RA than in OA (P < 0.01). Serum levels of IP-10 (3.1 +/- 1.2 ng/ml) were higher in patients with seropositive RA compared to controls (1.2 +/- 0.2 ng/ml) (P < 0.02). There was a gradient of IP-10, Mig, Mip-1 alpha, and Mip-1 beta from the blood into the synovial fluid in RA. Infiltrating T cells around high endothelial venules in RA synovium and 90 +/- 3% of SF CD3(+)CD4(+) T cells expressed CXCR3, and 85 +/- 2% of SF CD3(+)CD4(+) T cells expressed CCR5. Chemokines, including IP-10, Mig, Mip-1 alpha, and Mip-1 beta, may participate in the selective recruitment of CCR5(+)CXCR3(+) T cells to the inflamed synovium. (C) 2000 Academic Press.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 34 条
[1]   CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[2]   Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32 [J].
Benkirane, M ;
Jin, DY ;
Chun, RF ;
Koup, RA ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30603-30606
[3]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[4]   DETECTION OF INTERLEUKIN-8 BIOLOGICAL-ACTIVITY IN SYNOVIAL-FLUIDS FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND PRODUCTION OF INTERLEUKIN-8 MESSENGER-RNA BY ISOLATED SYNOVIAL-CELLS [J].
BRENNAN, FM ;
ZACHARIAE, COC ;
CHANTRY, D ;
LARSEN, CG ;
TURNER, M ;
MAINI, RN ;
MATSUSHIMA, K ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (09) :2141-2144
[5]   Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021
[6]  
Cooke SP, 1998, ARTHRITIS RHEUM, V41, P1135, DOI 10.1002/1529-0131(199806)41:6<1135::AID-ART24>3.0.CO
[7]  
2-N
[8]  
DIMITRIUBONA A, 1983, J IMMUNOL, V130, P145
[9]   A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen [J].
Forster, R ;
Mattis, AE ;
Kremmer, E ;
Wolf, E ;
Brem, G ;
Lipp, M .
CELL, 1996, 87 (06) :1037-1047
[10]  
Garred P, 1998, J RHEUMATOL, V25, P1462